Format

Send to

Choose Destination
J Med Econ. 2018 Mar;21(3):262-270. doi: 10.1080/13696998.2017.1397523. Epub 2017 Nov 14.

The economic burden of kidney disorders in Korea.

Author information

1
a Department of Rehabilitation Standard & Policy , Korea National Rehabilitation Research Institute , Seoul , Korea.

Abstract

AIMS:

To estimate the economic burden of kidney disorders in Korea.

MATERIALS AND METHODS:

The economic burden of kidney disorders was estimated using a prevalence-based approach. Related kidney diseases in patients with kidney disorders (RPWKD) were defined using codes from the tenth International Classification of Disease (E70-E90, F30-F48, F60-F69, F90-F99, K65-K67, N00-N08, N17-N19, and N30-N39). All diseases in patients with kidney disorders (APWKD) were defined as kidney disorders that involved all disease codes. Economic costs were divided into direct costs (medical costs and non-medical costs) and indirect costs (productivity loss because of morbidity and premature mortality).

RESULTS:

The prevalence of kidney disorders increased from 0.08% (2008) to 0.11% (2011). The total economic burden of RPWKD also substantially increased from $898.9 million (2008) to $1.43 billion (2011). This ∼59.4% increase in the economic burden was equal to 0.12% of the Korean gross domestic product. The economic burden of APWKD also increased during the study period: $1.06 billion (2008), $1.23 billion (2009), $1.44 billion (2010), and $1.46 billion (2011).

CONCLUSIONS:

The present study provides the first data regarding the economic burden of kidney disorders in Korea. The findings support the need for early intervention services and prevention programs to prevent, identify, and manage kidney disorders.

KEYWORDS:

Kidney disorders; Korea; cost analysis; economic burden; prevalence-based approach

PMID:
29069948
DOI:
10.1080/13696998.2017.1397523
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center